$TXTM .0002 Level 2 Is Thin... On Major Radar This

New Post Public Reply Private Reply Replies (0) Message Board
Compensated Post
pennybuster
$TXTM .0002 Level 2 Is Thin... On Major Radar This Week!!!




Protext Mobility Awarded U.S. Patent for "Systems and Methods for Monitoring Communications"


DELRAY BEACH, FL / ACCESSWIRE / November 4, 2014 / Protext Mobility (OTC Pink: TXTM) (TXTM), a developer of innovative and trusted applications for the mobile communications market, is pleased to announce that on November 04, 2014, the Company has been granted a new patent from the United States Patent and Trademark Office (USPTO); U.S. Patent No. 8,880,107 for "SYSTEMS AND METHODS FOR MONITORING COMMUNICATIONS."

The patent is related to technology developed by Protext Mobility, including intelligent systems and methods for efficiently monitoring communications of registered users and providing information about certain monitored communications; which include notifications regarding violations to authorized persons (e.g., parents). The patent is directed to one embodiment in which communications are monitored for violations (e.g., language or subject matter) in accordance with a sensitivity setting selected by an authorized person (e.g., a parent) and only communications which have violations not within the sensitivity setting are forwarded to the authorized person, including an indication of any violations (e.g., language, subject matter) identified in the communication. Communications are first normalized, and analyzing the normalized version of a communication for a violation may include utilizing a Bayesian algorithm to determine whether the communication includes a violation as identified in a predetermined set of violations.

"Issuance of this patent represents an important milestone for our Company. We have placed great importance on building unique intellectual property, and spent a large amount of time and financial resources to do so," commented Protext CEO Steve Berman. "These efforts have resulted in a wholly owned, proprietary technology platform for the mobile communications market. To date, we have released several mobile applications developed from the core platform that provide parents peace of mind as it relates to the dangers children encounter while using mobile technology, specifically with regards to Bullying, Sexting and Distracted Driving. These applications are marketed under Family Mobile Solutions for the consumer, Compliant Wireless for the enterprise and DriveAlert for distracted driving."

"While distracted driving continues to be our main focus, bullying and sexting incidents continue to rise and are considered to be an epidemic of a problem, on par with physically dangerous activities such as texting while driving." "We have plans on our technology development roadmap to develop additional applications through expanding the platform with new features and advanced functionality which can then be bundled and marketed as new mobile applications," Mr. Berman went on to say.

About Protext Mobility, Inc.

Protext Mobility (TXTM) develops innovative applications and trusted solutions for consumers and businesses operating in the mobile communications marketplace. The Company's mobile communications service offering provides consumers with mobile solutions to monitor text activity and curb device usage while driving, as well as businesses solutions' to help manage mobile communications activities amongst employees. Protext Mobility markets its services under the DriveAlert, FamilyMobileSolutions and CompliantWireless brands. For more information on the Company and its suite of mobile solutions for consumers and businesses, please visit http://www.protextmobility.net

Disclaimer:

The press release may include certain statements that are not descriptions of historical facts but are forward looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. These forward-looking statements are identified by words such as "may," "expects," "believes," "anticipates," "intends," "projects," or similar terms, variations of such terms or the negative of such terms and include statements regarding the potential impact of our new Drive Alert solution and the market opportunity for our new Drive Alert solution. There are a number of risks and uncertainties that could cause actual results to differ materially from the forward-looking statements made herein including the inability of our new Drive Alert solution to have the desired impact on the reduction of driving injuries. Such information is based upon various assumptions made by, and expectations of, our management that were reasonable when made but may prove to be incorrect. All of such assumptions are inherently subject to significant economic and competitive uncertainties and contingencies beyond our control and upon assumptions with respect to the future business decisions which are subject to change. Accordingly, there can be no assurance that actual results will meet expectation and actual results may vary (perhaps materially) from certain of the results anticipated herein. The Company has no obligation to update these forward-looking statements.

CONTACT:

Steve Berman

Chief Executive Officer

516-637-4061

investors@protextm.com

info@protextm.com

SOURCE: Protext Mobility
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Ivonescimab Promises New Hope for Advanced BTC Patients

Updated Category News Views 190

Shifting the Paradigm in Biliary Tract Cancer Treatment Here's the scoop from the bustling world of oncology: the trial of Ivonescimab plus chemotherapy is stirring waves among experts in advanced biliary tract cancer (BTC). Contrary to the usual drowsy mornings with coffee and market pages, this data from Hong Kong wasn't about Wall Street this time. This trial might...

Continue Reading
Johnson & Johnson's JNJ-6143 Shines in Prostate Cancer Study

Updated Category News Views 230

Prostate Cancer's Persistent Challenge No one in the healthcare game needs the reminder: prostate cancer is no walk in the park, especially for those grappling with advanced stages. Now picture this—you're on your sixth treatment, and the cloud is not lifting. It's a battle that never ends, with traditional therapies sometimes barely holding the line. JNJ-6143's New...

Continue Reading
TORRAS Cases Balance Protection with Slim Design for 2026

Updated Category News Views 144

Are Slim iPhone Cases Really Protecting Your Investment? Anyone who's dropped a brand-new phone knows the pain of watching your investment smack the concrete. But hey, welcome to 2026, where Consumer365's latest rundown on iPhone protective gear turns the spotlight on TORRAS. These folks grabbed attention with their Q3 Air and Q3 Air Pro cases, crafted for iPhone 18 Pro...

Continue Reading
Spooky Dining at CARNE: A Halloween Hit in Oxnard

Updated Category News Views 242

A Festive Transformation at CARNE Rolling into Oxnard, you're met with an unconventional dining spectacle at CARNE. It's not your average restaurant fare as they've pulled out the stops with their spirited Halloween pop-up, A Nightmare at CARNE. Channeling the eerie charm of "The Nightmare Before Christmas," this temporary transformation morphs the venue into a lively,...

Continue Reading
LexisNexis Debuts AI-Guided Field Clarity at IACP 2026

Updated Category News Views 59

LexisNexis Takes a Serious Step Forward The world of law enforcement reporting just got a shake-up. LexisNexis Coplogic Solutions launched a souped-up version of its Desk Officer Reporting System (DORS) at the IACP 2026 event. They paired DORS with Field Clarity, a newfangled AI-powered assistant that aims to make police reporting slicker and more accurate. You can bet...

Continue Reading
RYBREVANT's Promising Results in HNSCC Treatment

Updated Category News Views 80

Impressive Outcomes for RYBREVANT FASPRO in Head and Neck Cancer Tucked away in the endless cycle of drug trials, a glimmer of hope shines through with new data on RYBREVANT FASPRO in treating head and neck squamous cell carcinoma (HNSCC). This science talk might not rattle the ticker tape directly on NYSE:JNJ, but it has all the makings of a game-changer in the oncology...

Continue Reading
Survivors Secure $800M Settlement with NY Archdiocese

Updated Category News Views 299

Massive Settlement: A Long-Awaited Justice Here's a different kind of news that's hitting like a thunderbolt. Over 1,300 survivors of abuse have finally struck a landmark deal with the Archdiocese of New York. Not only are the numbers staggering, but the relief for these individuals is palpable. We're talking about more than $800 million on the table here. That's some...

Continue Reading
Innovent's IBI3001 Shows Promise in Phase 1 Trials

Updated Category News Views 242

Pioneering Path with IBI3001 at ESMO 2026 Navigating through the crowded landscape of oncology trials, Innovent Biologics recently rolled out some riveting Phase 1 clinical data for their new darling, IBI3001. Top brass from Innovent took to the European Society for Medical Oncology (ESMO) Congress stage to lay bare their findings. Obviously, when you're presenting a...

Continue Reading
Monster Energy Unleashes Gaming Frenzy at Cosm L.A. Event

Updated Category News Views 96

Where Energy Drinks and Digital Reality Collide Monster Energy sure knows how to throw a party, especially when it hinges on something as electrifying as Call of Duty: Modern Warfare 4. Imagine this: Cosm Los Angeles is decked out with a massive 87-foot LED dome, and every gamer, celeb, and influencer ready to dive right in. You can't make this stuff up. They've mashed...

Continue Reading
Hims & Hers Faces FTC Heat: Investor Class Action Looms

Updated Category News Views 104

Trouble Is Brewing for Hims & Hers Investors This isn't your typical quiet stroll through the park when it comes to Hims & Hers Health, Inc. (NYSE: HIMS). We're talking about a full-blown legal showdown that's unfolding faster than you can say 'telehealth scandal.' October 25, 2026, saw the kind of announcement that makes seasoned investors' hearts skip a beat if they've...

Continue Reading

Top 5 Most Recently Viewed Articles

Michael Burry Steps Back: Scion Asset Management Shuttered

Updated Category News Views 409

Michael Burry Withdraws Scion Asset Management Registration Michael Burry, renowned for his insightful market predictions, has recently decided to de-register his hedge fund, Scion Asset Management, LLC. This decision marks a significant transition in Burry's investment journey. Understanding the De-Registration Process According to the Securities and Exchange...

Continue Reading
Delta Air Lines Takes Legal Action Against CrowdStrike Over Disruption

Updated Category News Views 540

Delta Air Lines Challenges CrowdStrike in Court Delta Air Lines (NYSE: DAL) has taken a bold step by filing a lawsuit against CrowdStrike (NASDAQ: CRWD), arising from significant operational disruptions caused by a software update. This action is taking place in a Georgia state court, specifically the Fulton County Superior Court. Mass Flight Disruptions and Their...

Continue Reading
Innovative LungFit PH Gains Approval for Use in Australia

Updated Category News Views 178

Introduction of LungFit PH in Australia Beyond Air, Inc. (NASDAQ: XAIR) has exciting news for the medical field as it recently received market authorization for its LungFit PH system from the Australian Therapeutic Goods Administration (TGA). This development positions LungFit PH as a Class IIb medical device, designed to provide a controlled application of nitric oxide...

Continue Reading
Integral Molecular Introduces Paratope-PLUS™ for Antibody Claims

Updated Category News Views 169

Integral Molecular Unveils Paratope-PLUS™ for Enhanced Antibody Patenting This innovative technology aligns with new USPTO guidelines for writing robust antibody patent claims and supports advanced antibody engineering for unique intellectual property. Integral Molecular has launched a revolutionary service named Paratope-PLUS™. This new technology aims to improve...

Continue Reading
Nauticus Robotics Growth in Q2: A Positive Outlook Ahead

Updated Category News Views 223

Nauticus Robotics Shows Strong Growth Trajectory in Q2 Nauticus Robotics, Inc. (NASDAQ: KITT), a leading innovator in subsea robotics and software, has demonstrated remarkable momentum in its financial results for the second quarter. The company continues to expand its market presence and innovate its service offerings, reflecting a strong commitment to long-term,...

Continue Reading